PHARMAPAC (U.K.) LIMITED Financials
- Company number
- 03201556CopyCopy
- Registered office
- Unit 22, Valley Road Business Park, Bidston, Wirral CH41 7EL
- Incorporated
- 21/05/1996
Company snapshot
- Status
- Active
- Employees
- 142 (2025)
- Latest financial data
- 2025
- Accounts type
- Medium
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
1.16%vs 20242024: £8.13M
Total Assets
3.70%vs 20242024: £18.67M
Cash in Bank
-58.59%vs 20242024: £446.86K
Total Liabilities
29.34%vs 20242024: £4.75M
Employees
-8vs 20242024: 150
In 2025, PHARMAPAC (U.K.) LIMITED reported net assets of £8.22M. The same filing shows total assets of £19.36M, cash in bank of £185.03K and total liabilities of £6.14M. Reported headcount was 142 in 2025. Total Liabilities rose from £4.75M in 2024 to £6.14M in 2025 (29.34%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
1.16%from £8.13M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures PHARMAPAC (U.K.) LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+4%vs 2023+2% a year compound (CAGR)
Cash in Bank
-76.3%vs 2023-51.3% a year compound (CAGR)
Total Assets
+48.9%vs 2023+22% a year compound (CAGR)
Total Liabilities
+20.5%vs 2023+9.8% a year compound (CAGR)
Employees
+6.8%vs 2023+9Biggest increase
Total Assets+48.9%
£13.01M in 2023 to £19.36M in 2025
Biggest decrease
Cash in Bank-76.3%
£780.56K in 2023 to £185.03K in 2025
PHARMAPAC (U.K.) LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total assets, pointing to a broader asset base, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.
Ratios from the filed figures
Calculated from PHARMAPAC (U.K.) LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 42.47%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 31.73%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 3.01%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 0.96%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
- Revenue per employee
- £76.02K2025
- Reported turnover divided by the reported average number of employees, for the latest year both were filed. Shows how much revenue the business generates per employee.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for PHARMAPAC (U.K.) LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 5.56M | 8.37M | 7.91M | 8.13M | 8.22M |
| Total Assets£ | 29.49M | 20.86M | 13.01M | 18.67M | 19.36M |
| Cash in Bank£ | 12.60M | 3.15M | 780.56K | 446.86K | 185.03K |
| Total Liabilities£ | 23.93M | 12.50M | 5.10M | 4.75M | 6.14M |
| Employees | 157 | 137 | 133 | 150 | 142 |
PHARMAPAC (U.K.) LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for PHARMAPAC (U.K.) LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
PHARMAPAC (U.K.) LIMITED reported net assets of £8.22M for 2025. That compares with £8.13M in 2024, a change of 1.16%.
PHARMAPAC (U.K.) LIMITED reported total assets of £19.36M for 2025. That compares with £18.67M in 2024, a change of 3.70%.
PHARMAPAC (U.K.) LIMITED reported cash in bank of £185.03K for 2025. That compares with £446.86K in 2024, a change of -58.59%.
PHARMAPAC (U.K.) LIMITED reported 142 employees in 2025, compared with 150 in 2024.
Between 2023 and 2025, PHARMAPAC (U.K.) LIMITED's net assets rose by 4%, cash in bank fell by 76.3%, total assets rose by 48.9% and total liabilities rose by 20.5%. Net assets compounded at 2% a year across the two years to 2025, from £7.91M to £8.22M. Reported headcount went from 133 in 2023 to 142 in 2025 (+9).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.